Coherus’ Yusimry was first approved in 2021 and is the seventh FDA-approved Humira biosimilar and Image Credit: Michael Vi / Shutterstock. Coherus BioSciences has divested
By effectively harnessing this globally unparalleled and extensive health dataset, we have an opportunity to attract and engage global life sciences companies who are looking
In our increasingly interconnected world, technology has woven itself seamlessly into the fabric of our daily lives. From the moment we wake up, we find
As healthcare demands continue to surge, innovation is an ever-pressing necessity. At the heart of this transformation lies a precious resource, capable of revolutionising care
Alumis will begin trading on Nasdaq on 28 June. Image credit: Shutterstock / Stuart Monk. Hot on the heels of securing $259m in Series C
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal
What You Should Know: – Fabric, a healthcare technology company focused on care enablement, announced today the acquisition of MeMD from Walmart Inc. (NYSE: WMT).
What You Should Know: – Noom, the leader in digital health coaching for chronic disease prevention, is revolutionizing its platform with the launch of two
What You Should Know: – Inovalon, an innovator in cloud-based healthcare data solutions, announced a strategic partnership with the MEDITECH Alliance. – The strategic collaboration
What You Should Know: – 23andMe Holding Co., a leading player in preventative health and therapeutics, and Nightingale Health, a pioneer in biomarker testing, announced